Want to see IN:CIPLA full AI Analyst Report?
Cipla Ltd (CIPLA) Drug Pipeline
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Insulin Glargine, Insulin Lispro-Aabc | Diabetes Mellitus, Type 2 | Phase IV | Active Not Recruiting | A Study of LY900014 in Adult Participants With Type 2 Diabetes Mellitus in India | Apr 15, 2024 | ― |
| Albuterol Sulfate Inhalation Aerosol (90 Mcg Per Actuation), Ventolin Hfa 90Mcg/Actuation Inhalation Aerosol_#1, Ventolin Hfa, 90 Mcg/Inh Inhalation Aerosol_#2 | Bronchial Asthma | Phase III | Completed | BE Study of Albuterol Sulfate Inhalation Aerosol 90 mcg Per Actuation in Patients With Stable Mild Asthma | Nov 23, 2023 | ― |
| Budesonide 80 Μg And Formoterol Fumarate Dihydrate 4.5 Μg, Symbicort, 80 Mcg-4.5 Mcg/Inh Inhalation Aerosol | Asthma | Phase III | Completed | BE Study Budesonide 80 μg and Formoterol Fumarate Dihydrate 4.5 μg Inhalation Product in Asthma Patient | Mar 31, 2022 | ― |
| Fluticasone Propionate/Salmeterol 100/50 Μg, Advair Diskus 100/50 Dry Powder Inhaler, 60 Actuat | Bronchial Asthma | Phase III | Completed | BE Study of Fluticasone Propionate/Salmeterol Inhalation Powder in Asthma Patients | Dec 26, 2017 | ― |
| 90 Mcg Reference Product, 180 Mcg Reference Product, 90 Mcg Test Product | Bronchial Asthma | Phase III | Completed | Pharmacodynamic Bioequivalence of Metered Dose Inhalers of Albuterol Sulfate in Patients With Stable Mild Asthma | Dec 04, 2015 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Insulin Glargine, Insulin Lispro-Aabc | Phase IV | Diabetes Mellitus, Type 2 | Active Not Recruiting | A Study of LY900014 in Adult Participants With Type 2 Diabetes Mellitus in India | Apr 15, 2024 | ― |
| Albuterol Sulfate Inhalation Aerosol (90 Mcg Per Actuation), Ventolin Hfa 90Mcg/Actuation Inhalation Aerosol_#1, Ventolin Hfa, 90 Mcg/Inh Inhalation Aerosol_#2 | Phase III | Bronchial Asthma | Completed | BE Study of Albuterol Sulfate Inhalation Aerosol 90 mcg Per Actuation in Patients With Stable Mild Asthma | Nov 23, 2023 | ― |
| Budesonide 80 Μg And Formoterol Fumarate Dihydrate 4.5 Μg, Symbicort, 80 Mcg-4.5 Mcg/Inh Inhalation Aerosol | Phase III | Asthma | Completed | BE Study Budesonide 80 μg and Formoterol Fumarate Dihydrate 4.5 μg Inhalation Product in Asthma Patient | Mar 31, 2022 | ― |
| Fluticasone Propionate/Salmeterol 100/50 Μg, Advair Diskus 100/50 Dry Powder Inhaler, 60 Actuat | Phase III | Bronchial Asthma | Completed | BE Study of Fluticasone Propionate/Salmeterol Inhalation Powder in Asthma Patients | Dec 26, 2017 | ― |
| 90 Mcg Reference Product, 180 Mcg Reference Product, 90 Mcg Test Product | Phase III | Bronchial Asthma | Completed | Pharmacodynamic Bioequivalence of Metered Dose Inhalers of Albuterol Sulfate in Patients With Stable Mild Asthma | Dec 04, 2015 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Cipla Ltd (IN:CIPLA) have in its pipeline
Cipla Ltd IN:CIPLA is currently developing the following drugs: Insulin Glargine, Insulin Lispro-Aabc, Albuterol Sulfate Inhalation Aerosol (90 Mcg Per Actuation), Ventolin Hfa 90Mcg/Actuation Inhalation Aerosol_#1, Ventolin Hfa, 90 Mcg/Inh Inhalation Aerosol_#2, Budesonide 80 Μg And Formoterol Fumarate Dihydrate 4.5 Μg, Symbicort, 80 Mcg-4.5 Mcg/Inh Inhalation Aerosol, Fluticasone Propionate/Salmeterol 100/50 Μg, Advair Diskus 100/50 Dry Powder Inhaler, 60 Actuat, 90 Mcg Reference Product, 180 Mcg Reference Product, 90 Mcg Test Product. These drug candidates are in various stages of clinical development as the company works toward FDA approval.